pyrroles has been researched along with Hyperkalemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ito, S; Itoh, H; Okuda, Y; Rakugi, H; Yamakawa, S | 1 |
Rakugi, H; Sugimoto, K; Yamakawa, S | 1 |
Grafe, P; Lehmann-Horn, F; Spuler, A | 1 |
1 review(s) available for pyrroles and Hyperkalemia
Article | Year |
---|---|
Management of hyperkalemia during treatment with mineralocorticoid receptor blockers: findings from esaxerenone.
Topics: Humans; Hyperkalemia; Hypertension; Mineralocorticoid Receptor Antagonists; Pyrroles; Sulfones | 2021 |
1 trial(s) available for pyrroles and Hyperkalemia
Article | Year |
---|---|
Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Essential Hypertension; Female; Humans; Hyperkalemia; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Pyrroles; Sulfones; Treatment Outcome | 2019 |
1 other study(ies) available for pyrroles and Hyperkalemia
Article | Year |
---|---|
Cromakalim (BRL 34915) restores in vitro the membrane potential of depolarized human skeletal muscle fibres.
Topics: Barium; Benzopyrans; Cromakalim; Humans; Hyperkalemia; In Vitro Techniques; Membrane Potentials; Muscles; Paralysis; Pyrroles; Tolbutamide | 1989 |